🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for MGUS

Sleep Apnea in Patients With MGUS and MM NCT04114084n/a1 site📍 Iowa City Michael Tomasson · Tests: Bone Marrow Aspirate and Biopsy Promoting Diagnosis and Management of AL in Italy (ProDigALIty) NCT06383143n/a4 sites📍 Bari📍 Catania📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia · Tests: no intervention Rifaximin Versus No Intervention for the Treatment of IgG/IgA (Non-IgM) Monoclonal Gammopathy of Undetermined Significance NCT07209371Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Rifaximin, Biospecimen Collection Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone Therapy for Patients with MIDD NCT06418477Phase 23 sites📍 Beijing📍 Beijing📍 Guangzhou Peking University People's Hospital · Tests: Dara-CyBorD A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) NCT06083922Phase 211 sites📍 Boston📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: Cyclophosphamide, Bortezomib, Dexamethasone, Daratumumab Intestinal Flora and Immunity in Monoclonal Gammopathy Patients NCT06539832n/a1 site📍 Guanzhou Zhujiang Hospital FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease NCT07446777NA1 site📍 Miami University of Miami · Tests: Health Coaching, Prolonged Overnight Fasting (POF), Mediterranean Diet, Supportive Materials Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS NCT06559033n/a2 sites📍 Rouen📍 Rouen University Hospital, Rouen · Tests: Evaluation of the presence and number of mutated alleles of the GBA/PSAP genes in patients with MM or MGUS A Study to Assess the Effectiveness and Safety of Canakinumab in Clinical Use in Patients With Schnitzler's Syndrome NCT07598422n/a5 sites📍 Kobe📍 Ushiku📍 Kanoya Novartis Pharmaceuticals A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma NCT06140524Phase 239 sites📍 Baltimore📍 Boston📍 Ann Arbor Regeneron Pharmaceuticals · Tests: Linvoseltamab Pre-malignant States to Hematologic Malignancies in Firefighters NCT06870760n/a1 site📍 Charlotte Wake Forest University Health Sciences · Tests: Monoclonal Gammopathy, Complete Blood Count with differential (CBC w/ diff), Clonal hematopoiesis (CHIP) A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH NCT05283993n/a1 site📍 Beijing Peking University First Hospital · Tests: No intervention Whole Body MRI in Oncology NCT06895291n/a3 sites📍 Bologna📍 Meldola📍 Milan Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IR… · Tests: Whole Body-Magnetic Resonance Imaging (WB-MRI) CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study NCT06644625n/a1 site📍 Charlotte Wake Forest University Health Sciences · Tests: Blood draw for the laboratory assessment Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment NCT07448779n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia AutoInflammatory Disease Alliance Registry (AIDA) NCT05200715n/a112 sites📍 Algiers📍 Boumerdas📍 Adelaide University of Siena · Tests: No intervention is foreseen by the protocol. The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study NCT05965115n/a1 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: Sample of Blood A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma NCT05573802Phase 1, Phase 22 sites📍 Athens📍 Thessaloniki Hellenic Society of Hematology · Tests: Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone, Nirogacestat Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions NCT05361694n/a1 site📍 Miami University of Miami A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS) NCT06055894NA7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Omega-3, Curcumin, Probiotic, Whole food, plant-based diet (WFPBD) A Prospective Long-term Observational Study in Patients With Monoclonal Gammopathy of Undetermined Significance NCT05539079n/a1 site📍 Oxford Oxford University Hospitals NHS Trust The Effect of Daratumumab in Patients With Monoclonal Gammopathy of Renal Significance (MGRS) in Finland NCT06889948Phase 21 site📍 Helsinki Helsinki University Central Hospital · Tests: Daratumumab Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy NCT06690593n/a1 site📍 Guanzhou Zhujiang Hospital Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma NCT05597345Phase 21 site📍 Rochester University of Rochester · Tests: Selinexor Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma NCT02726750n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Biospecimen Collection, Laboratory Biomarker Analysis Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies NCT05136807n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Quality-of-Life Assessment, Questionnaire Administration Spanish Registry of Patients With IgM Monoclonal Gammopathies NCT05093153n/a51 sites📍 Mérida📍 Palma📍 Palma de Mallorca Fundación Española de Hematología y Hemoterapía Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution NCT07214324n/a4 sites📍 Bologna📍 Catania📍 Palermo Azienda USL Reggio Emilia - IRCCS · Tests: Collection of biological material Registry for Adults With Plasma Cell Disorders (PCD's) NCT03717844n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource NCT01408225n/a1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: tissue banking
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy